HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD.
후베이 롱샹 제약 기술 유한 회사 - 홈 페이지
Hubei Longxiang Pharmaceutical Technology Co., Ltd.는 2008년 1월 등록 자본금 1억 2200만 위안으로 설립되었습니다. 지배 주주는 Tianjin Ruipu Biotechnology Co., Ltd.(주식 코드: 300119)입니다. Longxiang Pharmaceutical은 2017년 4월에 신3차 이사회에 상장되었으며, 주식 코드는 871082입니다. 직원은 340명이 넘고 총자산은 5억 6천만 위안입니다.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Wuxue, China
- Website
- https://www.lxpharm.com
- Categories
- 의약품 제조, 화학제품 및 플라스틱, 수의학 제품 및 동물 건강
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- domain-registered (green), checked 2026-08-09 Domain registry record
- debarment-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- sanctions-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)